Adenocarcinoma of colon
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Adenocarcinoma of colon
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Adenocarcinoma of colon
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
ADENOCARCINOMA, COLONIC, SOMATIC
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Adult Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma.
|
29287241 |
2018 |
Adult Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
CDC7-dependent transcriptional regulation of RAD54L is essential for tumorigenicity and radio-resistance of glioblastoma.
|
29413763 |
2018 |
Bloom Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The hRAD54 protein belongs to a superfamily of DNA helicases, and mutations in genes with DNA helicase function have been found to be responsible for cancer-prone syndromes (xeroderma pigmentosum, Bloom syndrome, Werner syndrome). hRAD54 thus could be a candidate modifier gene in tumors characterized by allelic imbalance at 1p32, the chromosome region in which this gene is located.
|
10640146 |
2000 |
Brain Tumor, Primary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The top 370 probe sets that were differentially expressed between BCBM and both BC and prBT were in the majority comparably overexpressed in BCBM and included, e.g. the coding genes BCL3, BNIP3, BNIP3P1, BRIP1, CASP14, CDC25A, DMBT1, IDH2, E2F1, MYCN, RAD51, RAD54L, and VDR.
|
29287594 |
2017 |
Breast Cancer, Familial
|
0.300 |
GeneticVariation
|
disease |
ORPHANET |
|
|
|
Breast Carcinoma
|
0.420 |
GeneticVariation
|
disease |
BEFREE |
However, RAD54L rs1710286 and RPA1 rs11078676 were not observed to be associated with either the risk or survival of BC.
|
28940489 |
2017 |
Breast Carcinoma
|
0.420 |
Biomarker
|
disease |
HPO |
|
|
|
Breast Carcinoma
|
0.420 |
Biomarker
|
disease |
CTD_human |
|
|
|
Breast Carcinoma
|
0.420 |
AlteredExpression
|
disease |
BEFREE |
The top 370 probe sets that were differentially expressed between BCBM and both BC and prBT were in the majority comparably overexpressed in BCBM and included, e.g. the coding genes BCL3, BNIP3, BNIP3P1, BRIP1, CASP14, CDC25A, DMBT1, IDH2, E2F1, MYCN, RAD51, RAD54L, and VDR.
|
29287594 |
2017 |
Carcinoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
RAD54L (OMIM 603615, Locus Link 8438) has been proposed as a candidate oncosupressor in tumours bearing a non-random deletion of 1p32, such as breast or colon carcinomas, lymphomas and meningiomas.
|
12614485 |
2003 |
Childhood Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
CDC7-dependent transcriptional regulation of RAD54L is essential for tumorigenicity and radio-resistance of glioblastoma.
|
29413763 |
2018 |
Childhood Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma.
|
29287241 |
2018 |
Choroid Plexus Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
TAF12, NFYC, and RAD54L are oncogenes required to initiate and maintain choroid plexus carcinoma (CPC).
|
25998405 |
2015 |
Choroid Plexus Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Cross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes.
|
25965574 |
2015 |
Chronic Lymphocytic Leukemia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These findings indicate that germline mutations in RAD51, RAD51AP1, RAD51L1, RAD51L3, RAD52 and RAD54L are unlikely to be causal of an inherited predisposition to CLL.
|
18203022 |
2008 |
Combined immunodeficiency
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Since expression of mutant hRAD54 and restoration of functional Prkdc in scid cells cause the same effects, i.e. telomere shortening and reduced recombination rates at telomeres, these results argue that telomere elongation in scid cells is a complex trait resulting from interactions between homologous recombination mechanisms and DNA-PKcs.
|
15975611 |
2005 |
Diffuse Mixed-Cell Lymphoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Ductal Breast Carcinoma
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
familial chronic lymphocytic leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Germline mutations in RAD51, RAD51AP1, RAD51B, RAD51C,RAD51D, RAD52 and RAD54L do not contribute to familial chronic lymphocytic leukemia.
|
18203022 |
2008 |
Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
CDC7-dependent transcriptional regulation of RAD54L is essential for tumorigenicity and radio-resistance of glioblastoma.
|
29413763 |
2018 |
Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Serine/Threonine Kinase CHEK1-Dependent Transcriptional Regulation of RAD54L Promotes Proliferation and Radio Resistance in Glioblastoma.
|
29287241 |
2018 |